Close

Pharming (PHAR) announces US FDA approval of Joenja as the first and only treatment indicated for APDS

Go back to Pharming (PHAR) announces US FDA approval of Joenja as the first and only treatment indicated for APDS

Pharming Group (PHAR) Halted on Volatility

March 24, 2023 2:32 PM EDT

(Updated - March 24, 2023 2:32 PM EDT)

Pharming Group (NASDAQ: PHAR) Halted on Volatility

... More